Skip to main content
. 2021 Aug 23;49:1–37. doi: 10.1016/bs.enz.2021.06.004

Fig. 10.

Fig. 10

Favipiravir (Fvp) targets the holo-RdRp active site. Fvp bound in the active site readily adopts a conformation incapable of undergoing catalysis (left; PDB 7AAP[129]). By contrast, the correct conformation of the incoming nucleotide features a 120° rotation around the ribose O5′-α-phosphate bond, setting up an in-line nucleophilic attack by the p-RNA 3′-OH (right—modeled using PDB 6SZV[130]).